Login
Roast topics
Find topics
Find it!
From:
Pulmonary Fibrosis News
(Uncensored)
subscribe
IPF treatment, NXP002, Continues to Show Promise in Preclinical Studies
https://pulmonaryfibrosisnews.com/news/nuformixs-nxp002-ipf-shows-promise-preclinical-studies/
links
backlinks
Tagged with:
idiopathic pulmonary fibrosis
tranilast
nxp002
nuformix
preclinical studies
esbriet
ofev
Roast topics
Find topics
Roast it!
The inhaled NXP002 achieves significant levels in the lungs and lowers the production of scarring-promoting molecules, a study shows.
